Results 61 to 70 of about 8,118 (201)

Searching for LADA in patients with Hashimoto's thyroiditis: A tool for the prevention of LADA

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Autoimmune thyroid diseases (AITD), such as Hashimoto's thyroiditis (HT), frequently co‐occur with autoimmune diabetes, including latent autoimmune diabetes in adults (LADA). While guidelines recommend thyroid autoantibody screening in patients with autoimmune diabetes, the reverse approach—screening for diabetes‐related autoantibodies in AITD
Kozlowska Alicja Anna, Messina Maria Vittoria, Pozzilli Paolo   +2 more
wiley   +1 more source

Responses to antithyroid drugs and serum s(P)RR in patients with Graves’ disease.

, 2018
Responses to antithyroid drugs and serum s(P)RR in patients with Graves’ disease.
Shihori Kimura (5066948), Atsuhiro Ichihara (392936), Midori Yatabe (5066942), Kaoru Yamashita (5066951), Takashi Ando (381000), Junichi Yatabe (625892), Yasufumi Seki (5066945), Daisuke Watanabe (201397), Yuki Mizuguchi (5066957), Kanako Bokuda (479682), Satoshi Morimoto (392931), Noriyoshi Takano (5066954)   +11 more
core   +1 more source

Peri-operative concerns in a patient with thyroid storm secondary to molar pregnancy

Indian Journal of Anaesthesia, 2015
Awareness of the presence of thyroid function abnormalities in patients with molar pregnancy is important for its prompt diagnosis and management. We report the development of thyroid storm in the immediate post-operative period in a 25-year-old female ...
Tanvir Samra, Ranvinder Kaur, Neha Sharma, Lalita Chaudhary   +3 more
doaj   +1 more source

Amiodarone‐related thyroid dysfunction and associated outcomes in patients with heart failure—A nationwide cohort study

Journal of Internal Medicine, EarlyView.
Abstract Aim Amiodarone increases the risk of thyroid dysfunction, but the prognostic significance of this complication in patients with heart failure (HF) is uncertain. This study investigates the association between amiodarone‐related thyroid dysfunction and risk of HF hospitalization or death in a nationwide cohort.
Søren Lund Kristensen, Sam Aiyad Ali, Mads Ersbøll, Jawad Haider Butt, Rasmus Rørth, Lucas Malta Westergaard, Lauge Østergaard, Finn Gustafsson, Oren Caspi, Emil Fosbøl, Lars Køber, Christian Selmer   +11 more
wiley   +1 more source

HIGH THYROPEROXIDASE ANTIBODY TITERS MAY PREDICT RESPONSE TO ANTITHYROID DRUG TREATMENT IN GRAVES DISEASE: A PRELIMINARY STUDY [PDF]

, 2023
Background and aim. Antithyroid drugs are first treatment for Graves hyperthyroidism worldwide. Although remission can be achieved in approximately 40-50% of patients in 12-18 months with antithyroid drugs, this period can be extended up to 24 months. We
Firat, S., Culha, C., Kuskonmaz, S. M., Onder, C. E., Gokbulut, P., Koc, G., Omma, T.   +6 more
core   +1 more source

Clinical and biochemical changes following I-131 therapy for hyperthyroidism in patients not pretreated with antithyroid drugs

, 1999
Background: Radioiodine therapy (I-131) for the treatment of hyperthyroidism has been shown to be effective and safe. Despite the extensive experience with radioiodine therapy, the necessity for pretreatment with antithyroid drugs is controversial ...
Kerstens, MN, Leemhuis, MP, Hoving, J, Schade, JH, Koornstra, J J, Gort, HBW, Visscher, KJ   +6 more
core   +1 more source

Long-term outcomes of graves disease in children treated with anti-thyroid drugs

Pediatrics and Neonatology, 2020
Background: Graves disease (GD) is the most common cause of thyrotoxicosis in children and adolescents, accounting for 15% of all thyroid diseases during childhood.
Ya-Ting Chiang, Wei-Hsin Ting, Chi-Yu Huang, Shih-Kang Huang, Chon-In Chan, Bi-Wen Cheng, Chao-Hsu Lin, Yi-Lei Wu, Chen-Mei Hung, Hsin-Jung Li, Chia-Jung Chan, Yann-Jinn Lee   +11 more
doaj   +1 more source

Neonatal Surveillance Gaps in Maternal Graves' Disease: Findings From a Queensland Maternity Hospital

Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 3, June 2026.
ABSTRACT Background Graves' disease presents unique challenges in pregnancy due to the risk of neonatal morbidity and mortality from maternal TSH Receptor antibodies (TRAb). A maternity hospital in Queensland has implemented a policy to identify at‐risk neonates and facilitate follow‐up, including cord blood TRAb, thyroid function tests (TFTs), and ...
Umesha Pathmanathan, Annabel Wingate, Stephanie Teasdale   +2 more
wiley   +1 more source

Fulminant type 1 diabetes with high‐titer anti‐glutamic acid decarboxylase antibodies: Likely rapid progression from stage 2 to 3

Journal of Diabetes Investigation, Volume 17, Issue 5, Page 892-896, May 2026.
Abstract A 61‐year‐old man visited our hospital with a sudden onset of polydipsia and polyuria occurring 5 days prior, accompanied by a 5‐kg weight loss. A month prior, his glycated hemoglobin level was 6.2%. Precisely 8 days before the first visit, he had a fever, and hyperglycemic symptoms began shortly thereafter.
Megumi Sato, Junnosuke Miura, Hikaru Oyatsu, Yuka Yoshida, Shota Mochizuki, Michio Otsuki, Tomoko Nakagami   +6 more
wiley   +1 more source

Establishment of a mouse model of propylthiouracil‐induced antineutrophil cytoplasmic antibody‐associated vasculitis

Animal Models and Experimental Medicine, Volume 9, Issue 4, Page 822-828, April 2026.
This graphical abstract summarizes our study in which we established a novel murine model of antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitis. Neutrophil recruitment was induced using thioglycolate, followed by timed administration of propylthiouracil and phorbol 12‐myristate 13‐acetate to generate DNase I‐resistant neutrophil ...
Sakiko Masuda, Momo Uchizawa, Chihiro Terasaka, Takumi Abe, Tetsuro Nakamura, Yuka Nishibata, Yusho Ueda, Daigo Nakazawa, Utano Tomaru, Akihiro Ishizu   +9 more
wiley   +1 more source